Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@VisionMonday
visionmonday.com > eyecare > article > foundation-fighting-blindness-renames-its-venture-philanthropy-arm-as-the-gund-vision-fund

Foundation Fighting Blindness Renames Its Venture Philanthropy Arm as the Gund Vision Fund

10+ hour, 26+ min ago   (399+ words) COLUMBIA, Md. and RALEIGH, N.C.—The Foundation Fighting Blindness, a leading private funding source for retinal degenerative disease research, has announced the rebranding of its venture philanthropy arm, formerly the Retinal Degeneration Fund (RD Fund), to the Gund Vision Fund. The new…...

medicalxpress.com
medicalxpress.com > news > 2026-09-simple-perception-accurately-success-laser.html

Simple perception test can accurately predict success of laser surgery for age-related vision loss

1+ day, 15+ hour ago   (24+ words) medicalxpress.com This site can’t be reached medicalxpress.com refused to connect....

The Tiger's Roar
tigersroar.com > online_features > press_releases > article_088bd66f-916b-5ebc-aab1-2e00282cc750.html

LaserCare Eye & LASIK Center Expands Advanced Vision Services with New Location in Frisco, TX

2+ day, 24+ min ago   (0+ words) ...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > hexiris-ophthalmics-to-present-first-in-human-obi-glaucoma-data-at-five-fall-meetings-beginning-with-the-ophthalmology-futures-forum-in-london-1036534884

Hexiris Ophthalmics to Present First-in-Human OBi Glaucoma Data at Five Fall Meetings, Beginning with the Ophthalmology Futures Forum in London

4+ day, 19+ hour ago   (430+ words) Hexiris was founded by surgeons Dr. Houfar Sekhavat and Dr. Nir Shoham-Hazon after humanitarian missions in Gabon, Mozambique and Mexico, where they saw the same reality in every clinic: effective treatments for glaucoma exist, but far too many patients cannot…...

Newswise
newswise.com > articles > discovery-fills-a-gap-in-understanding-diagnosing-primary-ciliary-dyskinesia

Discovery Fills a Gap in Understanding, Diagnosing Primary Ciliary Dyskinesia

3+ day, 20+ hour ago   (671+ words) Atomic model of two transition zone doublet microtubules connected by the central linker complex Hair-like appendages called motile cilia beat in synchrony on cells in many parts of the body to keep fluids and particles moving along, such as clearing…...

Google News
aao.org > education > headline > weekly-journal-update-september-9-2026

Weekly Journal Update — September 9, 2026 - American Academy of Ophthalmology

4+ day, 17+ hour ago   (89+ words) Rate of Early Optic Nerve Head Swelling After NAION Symptom Onset May Help Predict Visual OutcomesOphthalmology, in press 2026 The CVI Range for Clinical Research Tool Shows Strong Reliability and Validity in ChildrenOphthalmology Science, July 2026 Compared With Other Diabetes Drugs, Semaglutide…...

@VisionMonday
mobile.visionmonday.com > business > article > prevent-blindness-to-honor-reade-fahs-with-2027-person-of-vision-award

VM - Prevent Blindness to Honor Reade Fahs With 2027 Person of Vision Award

5+ day, 14+ min ago   (91+ words) CHICAGO—Prevent Blindness, a leading national patient advocacy organization dedicated to protecting and preserving eye health, has announced that the 2027 Prevent Blindness Person of Vision Award will be presented to Reade Fahs, executive chairman, National Vision Holdings, Inc. (Nasdaq: EYE)....

Yahoo Finance
finance.yahoo.com > healthcare > articles > prevent-blindness-names-reade-fahs-183000982.html

Prevent Blindness Names Reade Fahs, National Vision, as its 2027 Person of Vision Award Recipient

4+ day, 20+ hour ago   (585+ words) Prevent Blindness, the nation's leading patient advocacy organization dedicated to protecting and preserving eye health, announced today that the 2027 Prevent Blindness Person of Vision Award will be presented to Reade Fahs, Executive Chairman, National Vision Holdings, Inc. ("National Vision"). The…...

Asianet Newsable
newsable.asianetnews.com > markets > ird-stock-hits-over-5-year-highs-opus-genetics-experimental-therapy-shows-early-promise-in-retinal-diseases-trial-articleshow-bzk8p1h

IRD Stock Hits Over 5-Year Highs – Opus Genetics Experimental Therapy Shows Early Promise In Retinal Diseases Trial

4+ day, 20+ hour ago   (340+ words) Shares of Opus Genetics (IRD) surged more than 30% on Wednesday, clocking its best-ever single-day gains, after the company said that a low dose of its experimental gene therapy showed meaningful improvements in visual function in patients suffering from retinal diseases....

@VisionMonday
visionmonday.com > launchpad > practice-management > article > sightview-introduces-new-platform-for-ophthalmologists-1

Sightview Introduces New Platform for Ophthalmologists

6+ day, 2+ hour ago   (424+ words) VisionMonday.com...